<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9500169</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20475</journal-id>
<journal-id journal-id-type="nlm-ta">Neurobiol Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurobiol. Dis.</journal-id>
<journal-title-group>
<journal-title>Neurobiology of disease</journal-title>
</journal-title-group>
<issn pub-type="ppub">0969-9961</issn>
<issn pub-type="epub">1095-953X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27363778</article-id>
<article-id pub-id-type="pmc">5010951</article-id>
<article-id pub-id-type="doi">10.1016/j.nbd.2016.06.014</article-id>
<article-id pub-id-type="manuscript">NIHMS802142</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Dynamin 1 isoform roles in a mouse model of severe childhood epileptic encephalopathy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Asinof</surname>
<given-names>Samuel</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mahaffey</surname>
<given-names>Connie</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Beyer</surname>
<given-names>Barbara</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Frankel</surname>
<given-names>Wayne N.</given-names>
</name>
<xref ref-type="author-notes" rid="FN2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boumil</surname>
<given-names>Rebecca</given-names>
</name>
</contrib>
<aff id="A1">The Jackson Laboratory, Bar Harbor, ME 04609</aff>
</contrib-group>
<author-notes>
<fn fn-type="present-address" id="FN1">
<label>1</label>
<p id="P1">Current address: Neurosciences Graduate Program, University of California, San Diego, La Jolla, CA 92093</p>
</fn>
<fn fn-type="present-address" id="FN2">
<label>2</label>
<p id="P2">Current address: Institute for Genomic Medicine, Columbia University Medical Center, NY, NY 10032</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>11</month>
<year>2017</year>
</pub-date>
<volume>95</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<!--elocation-id from pubmed: 10.1016/j.nbd.2016.06.014-->
<abstract>
<p id="P3">Dynamin 1 is a large neuron-specific GTPase involved in the endocytosis and recycling of pre-synaptic membranes and synaptic vesicles. Mutations in the gene encoding dynamin 1 (<italic>DNM1</italic>) underlie two epileptic encephalopathy syndromes, Lennox-Gastaut Syndrome and Infantile Spasms. Mice homozygous for the <italic>Dnm1</italic> “fitful” mutation, a non-synonymous coding variant in an alternatively spliced exon of <italic>Dnm1</italic> (exon 10a; isoform designation: Dnm1a<sup>Ftfl</sup>) have an epileptic encephalopathy-like disorder including lethal early onset seizures, locomotor and neurosensory deficits. Although fitful heterozygotes have milder recurrent seizures later in life, suggesting an additive or semi-dominant mechanism, the molecular etiology must also consider the fact that Dnm1a<sup>Ftfl</sup> exerts a dominant negative effect on endocytosis <italic>in vitro</italic>. Another complication is that the fitful mutation induces alterations in the relative abundance of Dnm1 splice variants; mutants have a downregulation of Dnm1a and an upregulation of Dnm1b, changes which may contribute to the epileptic pathology. To examine whether Dnm1a loss of function, Dnm1a<sup>Ftfl</sup> dominance or compensation by Dnm1b is the most critical for severe seizures, we studied alternate isoform-specific mutant mice. Mice lacking <italic>Dnm1</italic> exon 10a or <italic>Dnm1</italic> exon 10b have neither spontaneous seizures nor other overt abnormalities, suggesting that in normal conditions the major role of each isoform is redundant. However, in the presence of Dnm1a<sup>Ftfl</sup> only exon 10a deleted mice experience severe seizures. These results reveal functional differences between Dnm1a and Dnm1b isoforms in the presence of a challenge, i.e. toxic <italic>Dnm1</italic><sup>Ftfl</sup>, while reinforcing its effect explicitly in this model of severe pediatric epilepsy.</p>
</abstract>
<kwd-group>
<kwd>Dynamin</kwd>
<kwd>alternative isoform</kwd>
<kwd>epilepsy</kwd>
<kwd>seizure</kwd>
<kwd>endocytosis</kwd>
<kwd>fitful</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>